Abstract:Background: Primary triple-negative breast cancer (TNBC) is influenced by hypoxic microenvironments that promote metastasis and paclitaxel (PTX) resistance. However, few studies have attempted to understand how hypoxia promotes metastasis and drug resistance and provide a solution to these problems, especially in TNBC. Methods: Transcriptome sequencing of TNBC cells under hypoxic conditions was performed to identify C1QBP. The mechanism of HIF-1α induced C1QBP under both hypoxia and normoxia were investigated by ChIP-qPCR. Next the role of C1QBP in mediating metastasis and chemoresistance to PTX and regulating VCAM-1 were studied by in vitro and in vivo experiments. Then the anti-cancer effect of C1QBP inhibition in hypoxic environment was investigated. Furthermore, TCGA database and clinical tissue microarrays in our cohort were used to verify the correlation of C1QBP with the expression of HIF-1α, VCAM-1, and p65. Results: Here, we report that hypoxia-induced HIF-1α upregulated the expression of C1QBP; the inhibition of C1QBP notably blocked metastasis of TNBC cells and increased their sensitivity to PTX under hypoxic conditions in vitro and in vivo. Depletion of C1QBP decreased VCAM-1 expression by reducing p65 protein levels in the nucleus and, remarkably, suppressed the activation of hypoxia-induced PKC–NF-κβ signaling. Moreover, tissue microarray and immunohistochemical staining showed a positive correlation between the protein levels of C1QBP and that of p65 and VCAM-1 in breast cancer patients (especially TNBC). The analysis from TCGA database further confirmed the correlation between the mRNA levels of C1QBP, HIF-1α, and VCAM-1 in TNBC patients. Conclusions: Hypoxia-induced HIF-1α upregulates C1QBP expression of TNBC cells. Deregulated C1QBP may inhibit hypoxia-induced metastasis and PTX resistance along with reducing the activation of the PKC–NF-κβ–VCAM-1 axis. Targeting C1QBP in the presence of PTX may be a potential therapeutic against hypoxia-induced metastatic or drug resistant TNBC. Funding Statement: Haiyan Fund Project of Harbin Medical University Cancer Hospital (Grant number: JJQN 2018-06); Health Committee Fund Project of Heilongjiang Province (Grant number: 2019-056); National Natural Science Foundation of China, Grant/Award Numbers: 81972706; National Natural Science Foundation of China, Grant/Award Numbers: 81602639; National Natural Science Foundation of China, Grant/Award Numbers: 81602323; National Natural Science Foundation of China, Grant/Award Numbers: 81872149; Heilongjiang postdoctoral fundation (LBH-Z18222). Outstanding Youth Project of Heilongjiang Provincial Natural Science Foundation, Grant/Award Number: YQ2019H027; 9. Wu Lien‐ the Science Foundation of Harbin Medical University, Grant/Award Number: WLD‐ QN1706; Young Elite Training Foundation Grant of Harbin Medical University Cancer Hospital, Grant/Award Number: JY2016‐ 02; Distinguished Young Scholars of Harbin Medical University Cancer Hospital, Grant/Award Number: JCQN2018‐ 03.Declaration of Interests: The authors declare no conflict of interest. Ethics Approval Statement: The Medical Ethics Committee approved this study and all the relevant information was provided to the patients who were willing to participate in the study.

ZC3H12A inhibits tumor growth and metastasis of breast cancer under hypoxic condition via the inactivation of IL-17 signaling pathway

Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Retraction Note: Upregulation of Long Noncoding RNA ZEB1-AS1 Promotes Tumor Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma

Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer

Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer

Aberrant Expression of Enhancer of Zeste Homologue 2, Correlated with HIF-1α, Refines Relapse Risk and Predicts Poor Outcome for Breast Cancer.

Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer

Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α

TP53I11 Suppresses Epithelial-Mesenchymal Transition and Metastasis of Breast Cancer Cells

ZBTB7A regulates LncRNA HOTAIR-mediated ELAVL1/SOX17 axis to inhibit malignancy and angiogenesis in endometrial carcinoma

Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer

Hypoxia-Mediated C1QBP Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates VCAM-1 Expression Via Canonical Nf-Κβ Signaling

Abstract 2680: Knockout on enhancer of zeste homolog 2 in triple-negative breast cancer model alters immune signaling and decreases tumor progression and lung metastasis

HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia

Circ_0001667 promotes breast cancer cell proliferation and survival via Hippo signal pathway by regulating TAZ

The Zeb1-Cxcl1 Axis Impairs the Antitumor Immune Response by Inducing M2 Macrophage Polarization in Breast Cancer

Zinc-finger Protein 382 Antagonises CDC25A and ZEB1 Signaling Pathway in Breast Cancer

Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis